Abstract

Human T lymphotropic virus type 1 (HTLV-1) trans-activator/oncoprotein, Tax, impacts a multitude of basic cellular processes, including I-κB kinase (IKK) signaling, DNA damage repair, and mitosis. These activities of Tax have been implicated in leukemogenesis, but the underlying mechanisms remain unknown. IKK and its upstream kinase, transforming growth factor β activated kinase-1 (TAK1), contain ubiquitin-binding subunits, NF-κB essential modulator (NEMO) and TAK1 binding protein 2 (TAB2) respectively, which interact with K63-linked polyubiquitin. On this signaling platform, auto-phosphorylation and activation of TAK1 occurs, followed by TAK1-catalyzed IKK phosphorylation and activation. Here we demonstrate in vitro and in vivo that Tax stimulates ubiquitin E2 conjugating enzyme Ubc13:Uev1A (or Ubc13:Uev2) and ubiquitin E3 ligase ring finger protein 8 (RNF8) to assemble long and unanchored K63-linked polyubiquitin for TAK1 and IKK activation. The TAK1 so activated by Tax also promotes JNK phosphorylation. The inappropriate activation of RNF8 — an E3 ligase involved in DNA damage repair, cytokinesis, and centrosome function — by Tax can explain the pleiotropic effects of Tax on signaling pathways.

Highlights

  • Human T lymphotropic virus type 1 (HTLV-1) transactivator/oncoprotein, Tax, impacts a multitude of basic cellular processes, including I-B kinase (IKK) signaling, DNA damage repair, and mitosis

  • IKK and its upstream kinase, transforming growth factor b activated kinase-1 (TAK1), contain ubiquitin-binding subunits, NF-B essential modulator (NEMO) and TAK1 binding protein 2 (TAB2) respectively, which interact with K63linked polyubiquitin

  • The TAK1 so activated by Tax promotes JNK phosphorylation

Read more

Summary

Introduction

Human T lymphotropic virus type 1 (HTLV-1) transactivator/oncoprotein, Tax, impacts a multitude of basic cellular processes, including I-B kinase (IKK) signaling, DNA damage repair, and mitosis. HTLV-1 tax hijacks cellular ubiquitination machinery to assemble K63-linked polyubiquitin for canonical NF-B activation Yik-Khuan A Ho1*, Huijun Zhi1, Tara Bowlin1, Batsukh Dorjbal1, Subha Philip1, Muhammad A Zahoor1, Hsiu-Ming Shih2, Brian Schaefer1, JN Mark Glover3, Chou-Zen Giam1

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.